#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.
RSS   Newsletter   Contact   Advertise with us

Endologix appoints Dan Lemaitre to the board

Share on Twitter Share on LinkedIn
Staff writer | Irvine, Ca., USA | December 11, 2009
EndologixDecember 11, 2009, Irvine, Ca., USA - Endologix, a developer of minimally invasive treatments for aortic disorders, announced that Dan Lemaitre has joined the the board of directors.
Mr. Lemaitre most recently served as the President and CEO of CoreValve, a private company focused on percutaneous aortic valve replacement. Prior to joining CoreValve, Mr. Lemaitre was a Senior Vice President at Medtronic, where he led the company's strategic planning and corporate development. Prior to joining Medtronic, Mr. Lemaitre spent 28 years in the medical device field as an investment analyst. This included 18 years with SG Cowen, where he was a managing director and led the healthcare research team, and six years with Merrill Lynch.

Mr. Lemaitre holds a BA in Economics from Bethany College and an MBA from Bowling Green State University. Mr. Lemaitre is a Chartered Financial Analyst.